Specifically, Tregs can impair the anti-tumor function of effector T cells through direct contact or the secretion of inhibitory cytokines such as IL-10 and TGF-β (36), while M2-type macrophages promote angiogenesis and suppress T-cell activity by releasing mediators like VEGF and arginase (37). Here, VEGFA is linked to neoplasm.